Aptamer-target interaction descriptor
Aptamer-target interaction information
Interaction ID: 537
Aptamer sequence: ACTCAGCACGCGTGTAGGGAAAACCAACCGCCCACAAGCTGCATGCAACG
Target unique ID: 190
Aptamer ID Aptamer descriptor Target chemistry Target name Affinity Binding Conditions/Buffer PubMed ID
Apta_514 5bA8 Molecule Adenine 10 μM 100 mM HEPES, 500 mM NaCl, 5 mM MgCl2 (pH 7.3) 11705996
Structure information of aptamer
Aptamer Sequence: ACTCAGCACGCGTGTAGGGAAAACCAACCGCCCACAAGCTGCATGCAACG
The optimal secondary structure in dot-bracket notation: .....(((.((.(((.(((...........)))))).)))))........
The centroid secondary structure in dot-bracket notation: .....(((.((.(((.(((...........)))))).)))))........
The MFE structure
The Centroid structure
The mountain plot representation
Aptamer information
Type Detail Type Detail
Aptamer ID Apta_514 Description 5bA8
Aptamer chemistry DNA Length 50 nt
GC content 58.0% Molecular weight 15,336.87 Da
Molarity of 1 μg/μl solution 65.20 μM Number of G-quadruplexes No QGRS found
G-Score N/A Function Targeted binding
Sequence ACTCAGCACGCGTGTAGGGAAAACCAACCGCCCACAAGCTGCATGCAACG
Applications Binding to adenine
Target information
Type Detail Type Detail
PubChem ID 190 Molecular name Adenine
Molecular formula C5H5N5 Molecular weight 135.13
IUPAC name 7H-purin-6-amine InChIKey GFFGJBXGBJISGV-UHFFFAOYSA-N
LogP -0.065 Topological polar surface area 80.48
Hydrogen bond acceptor 4 Hydrogen bond donor 2

Synonym(s):
adenine; 73-24-5; 1H-Purin-6-amine; 6-Aminopurine; 9H-Purin-6-amine; 7H-Purin-6-amine; Vitamin B4; Adenin; Adeninimine; Leuco-4; 6-Amino-1H-purine; 6-Amino-3H-purine; 6-Amino-7H-purine; 6-Amino-9H-purine; 1,6-Dihydro-6-iminopurine; 3,6-Dihydro-6-iminopurine; Purine, 6-amino-; USAF CB-18; 1H-Purine, 6-amino; ADE; 9H-Purine, 1,6-dihydro-6-imino-; 1H-Purine-6-amine; CCRIS 2556; AI3-50679; 3H-Purin-6(7H)-imine; NSC 14666; UNII-JAC85A2161; 9H-Purine-6-amine; 9H-purin-6-ylamine; CHEBI:16708; 1H-Purine, 6-amino-; MFCD00041790; 134434-48-3; 1H-purin-6(9H)-imine; 6H-Purin-6-imine, 3,9-dihydro-, (Z)- (9CI); CHEMBL226345; 134434-49-4; 134454-76-5; 66224-66-6; JAC85A2161; 6H-Purin-6-imine, 1,7-dihydro-, (Z)- (9CI); 6H-Purin-6-imine, 1,9-dihydro-, (E)- (9CI); 6H-Purin-6-imine, 3,7-dihydro-, (Z)- (9CI); NSC-14666; 134461-75-9; Adenine [JAN]; NCGC00094856-01; Pedatisectine B; DSSTox_CID_2557; DSSTox_RID_76627; DSSTox_GSID_22557; adenine-ring; CAS-73-24-5; Leucon (TN); Adenine (8CI); Adenine (JAN/USP); Adenine [USP:JAN]; SR-05000001754; 6-Aminopurine (Adenine); EINECS 200-796-1; 3H-PURIN-6-AMINE; 1H-Purin-6-amine (9CI); 3H-Purin-6-amine (9CI); 3h-adenine; 6-amino purine; 6-amino-Purine; purin-6-amine; 1jys; 1nli; 1wei; 2pqj; 3kpv; [3H]adenine; Adenine, 1; Adenine,(S); ALBB-005925; 7H-purin-6-ylamine; 9H-Purin-6-yl-amin; Adenine-[15N2]; Spectrum_001106; 2p8n; 9H-Purin-6-yl-amine; SpecPlus_000535; Adenine, >=99%; 9H-Purin-6-amine #; Spectrum2_000583; Spectrum3_000616; Spectrum4_001891; Spectrum5_000542; 6-Aminopurine;Vitamin B4; 3H-purin-6(9H)-imine; bmse000060; bmse000861; bmse000995; Epitope ID:140097; SCHEMBL8110; 6-Aminopurine, Vitamin B4; Oprea1_057274; US9138393, Adenine; US9144538, Adenine; BSPBio_002152; KBioGR_002447; KBioGR_002562; KBioSS_001586; KBioSS_002571; ZINC882; 71660-30-5; MLS001066342; DivK1c_006631; SPECTRUM1500807; SPBio_000426; GTPL4788; 9H-Purine,6-dihydro-6-imino-; DTXSID6022557; BDBM33218; KBio1_001575; KBio2_001586; KBio2_002562; KBio2_004154; KBio2_005130; KBio2_006722; KBio2_007698; KBio3_001652; KBio3_003040; 1,9-Dihydro-6H-purin-6-imine; Adenine 100 microg/mL in Water; cMAP_000085; 7H-Purin-6-amine, min. 95%; BCPP000433; BDBM181146; HMS1921I14; HMS2092K20; HMS2269I04; Pharmakon1600-01500807; BCP02865; HY-B0152; NSC14666; VCA70030; Tox21_111348; Tox21_302108; BBL007925; CA0118; CCG-38506; HTS027705; NSC757793; s1981; STK387542; WLN: T56 BM DN FN HNJ IZ; AKOS000118903; AKOS005171607; Tox21_111348_1; (Z)-3,9-Dihydro-6H-purin-6-imine; AC-2028; AM83908; BCP9000233; CS-1984; DB00173; MCULE-6556342774; NSC-757793; SDCCGMLS-0066584.P001; NCGC00094856-02; NCGC00094856-03; NCGC00094856-05; NCGC00255120-01; 66224-67-7; 66224-69-9; 71660-29-2; AS-11841; BL008313; NCI60_000998; SMR000471871; SBI-0052324.P002; Adenine, Vetec(TM) reagent grade, >=99%; DB-013503; A0149; FT-0620943; FT-0656198; 4175-EP2270010A1; 4175-EP2270015A1; 4175-EP2270505A1; 4175-EP2272517A1; 4175-EP2275404A1; 4175-EP2292088A1; 4175-EP2292593A2; 4175-EP2295441A2; 4175-EP2295503A1; 4175-EP2295550A2; 4175-EP2298783A1; 4175-EP2301536A1; 4175-EP2301538A1; 4175-EP2303884A1; 4175-EP2305250A1; 4175-EP2305808A1; 4175-EP2311455A1; 4175-EP2316452A1; 73A245; Adenine, suitable for cell culture, BioReagent; C00147; D00034; P50008; Q15277; Z-1043; AB00052833-18; AB00052833-19; AB00052833_20; AB00052833_22; AB00052833_23; AB00052833_24; A935233; Q-200595; SR-05000001754-1; SR-05000001754-2; W-106856; Adenine, BioReagent, plant cell culture tested, >=99%; Adenine, European Pharmacopoeia (EP) Reference Standard; F0001-1848; Z1250132272; 6379C0E0-C1BB-4087-96C5-1DE281B8EA4C; Adenine, United States Pharmacopeia (USP) Reference Standard; Adenine, Pharmaceutical Secondary Standard; Certified Reference Material

Activity data

No relevant experimental diagram

Interaction ID 537
Target type Molecule
Target unique ID 190
Activity 10 μM
Binding Conditions/Buffer

100 mM HEPES, 500 mM NaCl, 5 mM MgCl2 (pH 7.3)

Assay

N/A

PubMed ID 11705996
Similar aptamers
Aptamer ID Aptamer chemistry Sequence Similarity
Apta_513 DNA TAGGGAAAACCAACCGCCCAGAACTGCAGCATAAC 60.00%
Apta_689 DNA CCACACAACAGCCTACGTGGATACACCACATACATCCCATAACCCCGTGTCATGTGTCG 55.93%
Apta_1268 DNA CACACACGCAGCAAGGTCGTCGATACAAAACGTATCGACCCGTCACAGACTGCCCCGGGT 53.33%
Apta_153 RNA CCACAGUUCAGAGGCACCGCGAACAAAACGCAAGACAGAGUGCCGACAAGAAC 52.83%
Apta_1219 DNA GCGCAGAACCGACAGCAAAACGGAAGTCCACCACGACTATTGGTGCCCAATCTACCGTA 52.54%
Apta_7 DNA CCAGTCTCCCGTTTACCGCGCCTACACATGTCTGAATGCC 52.00%
Apta_275 DNA AGTTGAATGGTGTGGTCACTTCCAGTCCCGCAGGGCACAC 52.00%
Apta_286 DNA TACTCCGTCACTTTAGTGGATATAACAACCTCCCTATGGG 52.00%
Apta_348 DNA ACTTGCTCTGATGCGACAACCTTTTGCCCAGATAGTAAGT 52.00%
Apta_512 DNA ATAGGACGATTATCGAAAATCACCAGATTGGACCCTGGTTAACGAT 52.00%
Apta_960 DNA CCCGAGGCACGAGGGGGAACGTATCGTCATGTGCCGGCCA 52.00%
Apta_1018 DNA ATCCCTGCAGTTTGGTAGGGTGCGAGCAACATCAGGCACCTGCAGG 52.00%
Apta_1095 DNA CCCTGAGGGGTGATGTGAATCCTAACAGTAAGGAGGAAGG 52.00%
Apta_979 DNA ATGAGTAGTGCGGAGGGATGTGAATACTGACGCGGTCATAGTCGCTGTTGTACCATTGA 50.85%
Apta_572 DNA CCGTAACCCTGCGGGGGGGGGAGAAGGCAATGGGGGACAACTCGCCGGTAGCCATCCATAT 50.82%
Apta_288 DNA ATCCAGAGTGACGCAGCATTTCATCGGGTCCAAAAGGGGCTGCTCGGGATTGCGGATATGGACACGT 50.75%
Apta_994 DNA GCAATGGTACGGTACTTCCGGACAGTGCTGAAAACTGTGACCCCCCAAAAGTGCACGCTACTTTGCTAA 50.72%
Apta_1017 DNA TAGGGAATTCGTCGACGGATCCCTGCAGTTTGGTAGGGTGCGAGCAACATCAGGCACCTGCAGGTCGACGCATGCGCCG 50.63%
Apta_142 DNA CGCACATCAGTTTAGCAGCGCCAAAGGCGGAAGCGCA 50.00%
Apta_155 RNA GACCCAGGGCCGGGACGCAAAGCAGCCAAAACAGACGGCCCCAGUCAGGGAGUU 50.00%